Strategies for Improving Case Reports Involving Patients With Rare Diseases
Mikaela I Poling, Craig R Dufresne

TL;DR
This paper suggests ways to improve the accuracy of case reports for rare diseases by emphasizing thorough research, expert involvement, and adherence to guidelines.
Contribution
The paper introduces specific quality-improvement strategies for rare disease case reports based on clinical experience.
Findings
Accurate case reports require recent literature review and in-person patient experience.
Involving rare disease experts enhances report accuracy.
Following case report guidelines and diagnostic criteria strengthens reporting.
Abstract
For those treating patients with rare diseases, there may be a disproportionate clinical reliance on the literature, compared with those treating patients with common problems. Moreover, the rare disease literature consists of a preponderance of case reports. Together, these factors place a higher burden for accuracy on authors of case reports of patients with rare diseases. Our decades of experience with the rare congenital craniofacial myopathy, Freeman-Sheldon syndrome-now, Freeman-Burian syndrome, and other rare diseases suggests that accurate and current information may not efficiently proliferate in the rare disease literature-a potentially significant clinical and scholarly concern. Based on our experience of reading case reports of patients with Freeman-Burian syndrome, we suggest mutually supporting mitigation strategies. Our quality-improvement strategies for rare disease case…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsGenomics and Rare Diseases · Health Systems, Economic Evaluations, Quality of Life
